Fidelity Investments’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-90
Closed -$17 5728
2024
Q1
$17 Buy
+90
New +$18 ﹤0.01% 5214
2023
Q3
Sell
-1,750
Closed -$1.55K 5576
2023
Q2
$1.55K Sell
1,750
-303
-15% -$257 ﹤0.01% 4649
2023
Q1
$1.55K Sell
2,053
-210
-9% -$274 ﹤0.01% 4684
2022
Q4
$2.6K Sell
2,263
-2,447
-52% -$2.02K ﹤0.01% 4446
2022
Q3
$4K Sell
4,710
-104
-2% -$126 ﹤0.01% 4427
2022
Q2
$5K Sell
4,814
-10,960
-69% -$9.41K ﹤0.01% 4344
2022
Q1
$22K Buy
+15,774
New +$33.7K ﹤0.01% 3980

Other funds holding AFIB

Fidelity Investments's AFIB Position: Q2 2024 in Review

Fidelity Investments sold out of Acutus Medical Inc (AFIB) in Q2 2024, closing a stake of 90 shares — an estimated $17 sold.

Fidelity Investments first reported a position in AFIB in Q1 2022 and held it in 7 quarters. The position peaked at $22K in Q1 2022. 1 fund tracked by Wall St. Rank holds AFIB as of Q2 2024.

  • Fidelity Investments reported no remaining Acutus Medical Inc position as of Q2 2024 after selling out during the quarter.
  • Fidelity Investments sold 90 Acutus Medical Inc shares in Q2 2024, an estimated $17.
  • Fidelity Investments first reported a position in Acutus Medical Inc in Q1 2022 and held it in 7 quarters.
  • Fidelity Investments's Acutus Medical Inc position peaked at $22K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2024.

Based on Fidelity Investments's 13F filing for Q2 2024, filed 13 Aug 2024.